Labostro, Justine Lyka .
HRN: 24-49-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/06/2024
CEFUROXIME 500MG (TAB)
07/06/2024
07/12/2024
PO
500mg
BId
Nsvd
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes